Sun Pharmaceutical Industries Ltd.

NSE: SUNPHARMA | BSE: 524715 | ISIN: INE044A01036 | Industry: Pharmaceuticals
| Falling Comet
1603.8000 16.90 (1.06%)
NSE Aug 11, 2025 11:17 AM
Volume: 235.3K
 

1603.80
1.06%
Phillip Capital
SUNP received final approval from US FDA for gGleevec with 180days marketing exclusivity in the US and is set to launch it on February 1, 2016 (as per its settlement agreementwithNovartis).WehadearliermodeledgGleevecopportunityconsideringthe...
Number of FII/FPI investors decreased from 1351 to 1326 in Jun 2025 qtr
More from Sun Pharmaceutical Industries Ltd.
All Rapid Results
Recommended